Dupilumab effectiveness in a case of prurigo nodularis and severe recalcitrant hidradenitis suppurativa

Ital J Dermatol Venerol. 2024 Jun;159(3):370-371. doi: 10.23736/S2784-8671.24.07844-7. Epub 2024 Apr 12.

Authors

Raffaele D Caposiena Caro¹, Giulia Bazzacco², Enrico Zelin², Vanessa Mazzoletti³, Marina Agozzino², Diego Signoretto⁴, Nicola DI Meo², Iris Zalaudek²

Affiliations

¹ Clinic of Dermatology, Hospital Maggiore of Trieste, University of Trieste, Trieste, Italy - [email protected].
² Clinic of Dermatology, Hospital Maggiore of Trieste, University of Trieste, Trieste, Italy.
³ Department of Health Science, University of Eastern Piedmont, Novara, Italy.
⁴ Department of Histopathology, Cattinara Hospital of Trieste, Trieste, Italy.

PMID: 38619203
DOI: 10.23736/S2784-8671.24.07844-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized* / therapeutic use
Female
Hidradenitis Suppurativa* / drug therapy
Humans
Male
Prurigo* / drug therapy
Severity of Illness Index

Substances

Antibodies, Monoclonal, Humanized
dupilumab